echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > It's sunny, the sea is... 11 pharmaceutical companies "besieged" 2 billion injections

    It's sunny, the sea is... 11 pharmaceutical companies "besieged" 2 billion injections

    • Last Update: 2021-01-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network January 8th, January 7th, NMPA official website shows that Nanjing Zhengda Tianqing, Yangzijiang Pharmaceutical Group, Nanjing Sheng and Pharmaceuticals injection of Parecheb sodium through a consistent evaluation.
    January 6, Haizheng Pharmaceuticals announced that the company's injection of parrexib sodium over-evaluation.
    injection with parexib sodium for the fourth batch of harvest varieties, so far 11 pharmaceutical companies have been evaluated.
    Parexib belongs to nonsteroidal anti-inflammatory drugs, is the world's first simultaneous intravenous, intramuscular injection of selective epoxygenase-2 inhibitors, compared with traditional non-selective epoxyase inhibitors, with good analgesic effect, rapid effect, long-lasting effect, can effectively suppress pain hypersensitivity, high gastrointestinal safety, does not affect platelet function, does not increase cardiovascular risk and so on. according to
    meters of intranet data, in 2019 China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal injection of Parrisheb sodium sales of nearly 2 billion yuan, 2020H1 sales of more than 900 million yuan, an increase of 14.57 percent year-on-year.
    injection with Parexib sodium has previously been evaluated enterprise sources: Mi-Net consistency evaluation database injection with Parexib sodium for the fourth batch of collection varieties, before there have been Colum, Qiru, Osaikang ... 8 companies have been evaluated.
    With nanjing Zhengda Tianqing, Yangzijiang Pharmaceutical Group, Nanjing Sheng and pharmaceutical companies such as the product evaluation, the current injection of Parexib sodium evaluation enterprises have reached 11.
    so fierce competition, the fourth batch of the collection of the price of the variety is worth paying attention to.
    source: MiNet Database, NMPA
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.